| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.21 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |